SHARE
COPY LINK

HEALTH

Coronavirus: Is a lockdown extension inevitable in Switzerland?

Will Switzerland’s coronavirus measures be extended beyond February 28th?

Coronavirus: Is a lockdown extension inevitable in Switzerland?
Photo: FABRICE COFFRINI / AFP

Switzerland’s coronavirus measures are in place until at least February 28th. 

On Monday, Swiss media reported Health Minister Alain Berset indicated not only would the lockdown be extended, but that a range of tighter measures were being considered. 

READ MORE: Switzerland likely to tighten coronavirus measures to 'save summer': reports 

This is despite infection rates falling across much of the country. 

On Friday however, Berset indicated however that the Federal Council hadn’t ruled out a relaxation of at least some of the existing measures. 

Speaking with French-language newspaper Le Nouvelliste, Berset said an easing of measures was likely. 

“The Federal Council is likely to announce easing, because you have to be able to live.”

“The Federal Council will draw up the measures next week. Then there will be a consultation with the cantons,” he said. 

Berset said that not all measures would be relaxed – and declined to say which ones were likely to be eased. 

“We have to be careful. The Federal Council understands the frustration in the population. The Federal Council would also like to see easing, that's clear.”

He did however appeal to the population to stick to the rules in order to bring about an end to the lockdown sooner. 

“If we want to prevent the situation from deteriorating, every last person must play along and adhere to the restrictions.”

‘No Covid group’

Motivated by the approaches taken in island countries such as Australia, Japan, Taiwan and New Zealand, Switzerland’s No Covid group is pushing for a tighter set of rules. 

According to Switzerland’s NZZ newspaper, the strategy is based on “rigorous containment and rigorous testing”. 

Under the plan, lockdowns are to be applied regionally – whether that be in municipalities, cities or cantons – and would only be lifted where the infection rate is 10 new infections over 14 days per 100,000 residents. 

Currently, Switzerland’s infection rate is just over 250 new infections per 100,000 residents over the past 14 days – with not one canton having a lower rate than that suggested by the No Covid group. 

The idea has been criticised, primarily from those who point out that Switzerland’s geography and integration with border areas makes it far more difficult to isolate regions than in the aforementioned island nations. 

 

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.
For members

HEALTH

Which medications in Switzerland are set to become more expensive?

The cost of medications in Switzerland is already quite a bit higher than elsewhere in Europe. And now certain drugs will become even pricier.

Which medications in Switzerland are set to become more expensive?

Swiss consumers pay significantly more for their medicines than those in neighbouring European countries. 

This is what emerges from various data published over the years.

“In Switzerland, we pay far too much for medicines compared to abroad,” Matthias Müller, a spokesperson for SantéSuisse, an umbrella group for Swiss health insurance providers, told Swiss media in 2023. 

Even the price of many generic medicines is twice as high in Switzerland as in nine EU countries.

For instance, generics are on average 48 percent cheaper in Belgium, Denmark, Germany, Finland, France, Great Britain, the Netherlands, Austria and Sweden than in Switzerland, according to a price comparison.

And prices for a number of commonly-used drugs will rise even further in the near future.

Why is that?

The Federal Office of Public Health (FOPH) is adapting a new model for calculating the distribution margin. 

A distribution margin is the difference between the distributor’s cost of acquiring goods and the price at which those goods are sold.

From July 1st, 2024, inexpensive medicines whose factory price is less than, or equal to, 15 francs will become more expensive.

This change will affect more than half of medications currently being sold in Switzerland.

As a result of this move, “additional costs of several hundred million will be passed on to patients,” according to Intergenrika, which represents generic drug manufacturers in Switzerland. 

In a nutshell, consumers will pay slightly lower prices for medicines that were previously more expensive, but will also end up paying more  for those that are currently cheaper – like generics.

Which meds will become more expensive?

Pain medications are among those set to become pricier.

One of them is ibuprofen, a popular anti-inflammatory.

While a box of 20 400-mg tablets today costs 5.92 francs, its price will practically double to 11 francs from July 1st.

Though its manufacturing cost will remain the same as today – 1.58 francs – the distribution margin will increase from 4.19 to 9.09 francs.

The same goes for another often-used pain medication, Ponstan.

Ten 500-mg tablets will cost 11.21 francs instead of 6.19 currently.

The manufacturer will continue to charge 1.82 francs for the drug, but the distribution margin will increase from 4.22 to 9.11 francs.

And even generic drugs, which are cheaper – and often by much – will get pricier, at consumers’ expense.

Will some drugs be cheaper?

Yes, some will become slightly less expensive.

One example is the anticoagulant Rivaroxaban whose price will drop from 281 to 267 francs.

READ ALSO: Why you will pay more for certain drugs in Switzerland 2024?

SHOW COMMENTS